Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Clinical trial NCT01713738 · COMPLETED

Trial details

NCT number: NCT01713738
Sponsor: Neufeld, Ellis J, MD, PhD
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura (ITP)Immune Thrombocytopenic Purpura (ITP)

Start date: 2003-05-01
Primary completion: 2005-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.